Privia Health Group, Inc. (NASDAQ:PRVA) Given Consensus Rating of “Moderate Buy” by Brokerages

Shares of Privia Health Group, Inc. (NASDAQ:PRVA) have received an average recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the company, MarketBeat reports. Two equities research analysts have rated the stock with a hold rating, eleven have issued a buy rating and one has issued a strong buy rating on the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is $24.54.

A number of equities analysts recently issued reports on PRVA shares. Baird R W raised shares of Privia Health Group to a “strong-buy” rating in a report on Thursday, May 30th. Canaccord Genuity Group cut their price target on Privia Health Group from $37.00 to $26.00 and set a “buy” rating for the company in a report on Friday, May 10th. Stifel Nicolaus decreased their price objective on Privia Health Group from $28.00 to $24.00 and set a “buy” rating on the stock in a research note on Wednesday, May 1st. Robert W. Baird began coverage on shares of Privia Health Group in a report on Thursday, May 30th. They issued an “outperform” rating and a $23.00 target price for the company. Finally, Evercore ISI decreased their target price on shares of Privia Health Group from $23.00 to $20.00 and set an “outperform” rating on the stock in a research note on Tuesday, July 9th.

Privia Health Group Price Performance

PRVA stock opened at $19.17 on Wednesday. Privia Health Group has a 1 year low of $15.92 and a 1 year high of $28.10. The company has a market cap of $2.29 billion, a P/E ratio of 127.80, a price-to-earnings-growth ratio of 3.00 and a beta of 0.78. The stock’s fifty day moving average price is $17.30 and its 200-day moving average price is $19.17.

Privia Health Group (NASDAQ:PRVA) last posted its earnings results on Thursday, May 9th. The company reported $0.02 earnings per share for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.03). The firm had revenue of $415.24 million during the quarter, compared to the consensus estimate of $435.07 million. Privia Health Group had a net margin of 1.11% and a return on equity of 3.13%. As a group, analysts expect that Privia Health Group will post 0.2 earnings per share for the current year.

Insider Transactions at Privia Health Group

In related news, EVP Thomas Bartrum sold 2,252 shares of the firm’s stock in a transaction on Tuesday, April 30th. The shares were sold at an average price of $18.42, for a total transaction of $41,481.84. Following the completion of the transaction, the executive vice president now directly owns 103,862 shares of the company’s stock, valued at $1,913,138.04. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Privia Health Group news, CFO David Mountcastle sold 2,320 shares of Privia Health Group stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total value of $42,734.40. Following the sale, the chief financial officer now owns 259,959 shares of the company’s stock, valued at approximately $4,788,444.78. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Thomas Bartrum sold 2,252 shares of the company’s stock in a transaction that occurred on Tuesday, April 30th. The stock was sold at an average price of $18.42, for a total value of $41,481.84. Following the sale, the executive vice president now directly owns 103,862 shares in the company, valued at $1,913,138.04. The disclosure for this sale can be found here. Over the last quarter, insiders have purchased 293,235 shares of company stock valued at $4,745,481 and have sold 45,457 shares valued at $827,810. Insiders own 14.20% of the company’s stock.

Institutional Investors Weigh In On Privia Health Group

Several large investors have recently bought and sold shares of PRVA. Nisa Investment Advisors LLC lifted its position in Privia Health Group by 107.5% during the second quarter. Nisa Investment Advisors LLC now owns 1,795 shares of the company’s stock valued at $31,000 after purchasing an additional 930 shares during the last quarter. Park Place Capital Corp increased its stake in Privia Health Group by 115.4% during the first quarter. Park Place Capital Corp now owns 2,492 shares of the company’s stock worth $49,000 after acquiring an additional 1,335 shares during the last quarter. Benjamin Edwards Inc. lifted its stake in shares of Privia Health Group by 44.9% in the 4th quarter. Benjamin Edwards Inc. now owns 3,239 shares of the company’s stock valued at $75,000 after purchasing an additional 1,003 shares during the last quarter. Covestor Ltd lifted its stake in shares of Privia Health Group by 25.5% in the 1st quarter. Covestor Ltd now owns 5,292 shares of the company’s stock valued at $104,000 after purchasing an additional 1,076 shares during the last quarter. Finally, SG Americas Securities LLC purchased a new position in shares of Privia Health Group in the 1st quarter worth approximately $131,000. Institutional investors own 94.48% of the company’s stock.

Privia Health Group Company Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.